The research was done by infection control experts at Rochester General Hospital in Rochester, N.Y., who are on the faculty at the University of Rochester Medical Center.
"I was pleasantly surprised by the results," said Ann Falsey, M.D., who led the study. "Rapid testing does give physicians evidence to discontinue antibiotics, and some physicians are responding to the evidence.
Falsey's team analyzed the records of 166 patients who definitely had the flu when hospitalized. Eighty-six of the patients tested positive with the rapid test, which gives an answer within minutes, while the 80 others either did not have the rapid test done, or they tested negative at the time but were later found to have the flu. The team checked the subsequent treatment to see if there was a difference in the use of antibiotics, which aren't effective or useful against viruses like the flu.
They found that 86 percent of the patients whose flu was confirmed early on were treated with antibiotics, compared to 99 percent of the patients whose flu wasn't identified immediately. It's not a huge difference in numbers, but the study showed that the difference is significant, demonstrating that the rapid test does reduce the use of antibiotics in the hospital.
"At least some proportion of doctors is willing to stop antibiotics when patients have a documented viral infection," said Falsey. "This is certainly encouraging, but there is a lot more work to do."
The issue is important, says Falsey, because the over-use of antibiotics makes patients and the community more vulnerable to dangerous microbes resistant to most treatments. It's particularly important in hospitals, where people most prone to infection are treated.
Yet, Falsey noted in the study that 61 percent of patients who were generally at low risk for bacterial infection continued to receive antibiotics. She says that the prescription of antibiotics to patients with a viral infection is often done by doctors who believe that their patient may also have a bacterial infection or that antibiotics will prevent subsequent bacterial infections that could occur while the person is weak with the flu or another virus. In the current study, for instance, those patients with the flu who were still receiving antibiotics tended to be older, smokers, and have breathing difficulties. In other words, they were the ones most vulnerable to such an infection.
Nevertheless, Falsey notes that there have been no studies proving that such a practice is effective at preventing infections.
"Doctors are trying to do the right thing by their patients. Sometimes they perceive antibiotics as the safest choice, even though a virus may be the cause of their patient's illness," said Falsey, noting that 90 percent of people with the flu who see a doctor are given antibiotics, even though the drugs won't help.
The simplest solution to antibiotic resistance would be for doctors to not prescribe antibiotics when they're unlikely to help, such as when a patient definitely has the flu, the common cold, or most cases of sore throat. But when patients don't feel well, many march into their doctor's office expecting an answer and feel neglected if they don't receive a prescription in return for their visit. That leaves doctors caught between prescribing medication that probably won't help, vs. appearing unhelpful to their patients.
"Oftentimes people get sick, they just want to feel better, and they assume there is a pill that will make them better quickly," said Falsey. "Unfortunately, that's not the case for many respiratory illnesses that are caused by viruses. Instead they should rest, drink plenty of fluids, and take over-the-counter medications to help ease their symptoms. But many patients don't want to hear that, and it can be difficult for a doctor to deliver the news."
Tom Rickey | EurekAlert!
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
19.03.2018 | Physics and Astronomy
19.03.2018 | Materials Sciences
19.03.2018 | Event News